In opening remarks for the first NIBR Science of Therapeutics (NSofT) Symposium, NIBR President Jay Bradner welcomes attendees to a “ruthlessly scientific, atomic-level gathering of drug hunters motivated and interested in” developing antiviral therapeutics for coronaviruses – including the SARS-CoV-2 virus responsible for the global pandemic.
Part of the NIBR Science of Therapeutics Symposium on Coronavirus Antivirals, June 8, 2021.
Learn more: [ Ссылка ]
©2021 Novartis AG
